MedTrace Logo

Self-Acupressure and Social Jet Lag in Female Health Sciences Students

NCT07410936 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-02-17

No results posted yet for this study

Summary

This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on social jet lag, sleep patterns, and sleep quality in female health sciences students. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be performed daily for 12 weeks. Outcomes will be assessed at baseline and at the end of the intervention period, with the primary outcome being the change in social jet lag. Secondary outcomes include changes in sleep quality, daytime sleepiness, and participant blinding assessment.

Conditions

  • Social Jet Lag
  • Sleep Disturbance
  • Sleep Quality
  • Circadian Rhythm Disruption

Interventions

OTHER

Self-Acupressure Intervention

Participants receive structured training in self-administered acupressure at predefined acupoints (HT7, SP6, and Yintang). Training is provided face-to-face at baseline. Participants are instructed to apply acupressure daily at home using moderate, comfortable, non-painful pressure. Each session is performed according to the study protocol for a total duration of 12 weeks.

OTHER

Sham Self-Acupressure

Participants receive structured training in sham self-acupressure matched to the experimental intervention in frequency, session duration, and pressure. Sham acupressure is applied daily at non-acupoint locations that are not recognized as therapeutic acupressure points, using moderate, comfortable, non-painful pressure, for a total duration of 12 weeks.

Sponsors & Collaborators

  • Nigde Omer Halisdemir University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-15
Primary Completion
2026-05-15
Completion
2026-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07410936 on ClinicalTrials.gov